Malignant Transformation of Neurofibromas in Neurofibromatosis 1 Is Associated with CDKN2A/p16 Inactivation
Open Access
- 1 December 1999
- journal article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 155 (6), 1879-1884
- https://doi.org/10.1016/s0002-9440(10)65507-1
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- High frequency of p16INK4A gene alterations in hepatocellular carcinomaOncogene, 1999
- CDKN2A Gene Deletions and Loss of p16 Expression Occur in Osteosarcomas That Lack RB AlterationsThe American Journal of Pathology, 1998
- Benign neurofibromas in type 1 neurofibromatosis (NF1) show somatic deletions of the NF1 geneNature Genetics, 1995
- Cytogenetic findings in malignant peripheral nerve sheath tumorsInternational Journal of Cancer, 1995
- Neurofibromatosis Type 1: Pathology, Clinical Features and Molecular GeneticsBrain Pathology, 1995
- Cytogenetic analysis of soft tissue sarcomasCancer Genetics and Cytogenetics, 1994
- MTS1/CDKN2 gene mutations are rare in primary human astrocytomas with allelic loss of chromosome 9pHuman Molecular Genetics, 1994
- Germline p16 mutations in familial melanomaNature Genetics, 1994
- A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4Nature, 1993
- Molecular genetic analysis of tumors in von recklinghausen neurofibromatosis: Loss of heterozygosity for chromosome 17Genes, Chromosomes and Cancer, 1989